Serum anti-p53 antibody titers predict pathological response to preoperative chemotherapy in women with HER2 positive or triple negative breast cancer. - Yoshiyama, T.; Nakamura, Y.; Igawa, A.; Saruwatari, A.; Shigechi, T.; Ueda, N.; Kuba, S.; Ishida, M.; Nishimura, S.; Nishiyama, K.; Ohno, S. (Cancer Research, 2012)